SVFC Stock | News | Quote | Stock Forum | Tuesday, March 11,

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
$SVFC Intellicell Biosciences, Inc. SVFC Company Overview 

Intellicell Biosciences, Inc. SVFC Current Price and Quotes
Last Price 0.0099
Previous Close 0.0067 Open 0.0072
Daily Range 0.0103 - 0.0067 52wk Range 0.1975 - 0.0012
Volume 185,385,479 Dividend N/A
Average Vol (3m) 66,715,092 Yield N/A

SVFC Stock Message Board http://investorshangout.com/search?q=SVFC&...mp;yt1=Go!

Last Updated: Tuesday, March 11, 2014 01:07:54 AM

Intellicell Biosciences, Inc. SVFC

Company Updated Profile
Company Information

460 Park Avenue
17th Fl
New York, NY 10022

Website: http://www.intellicellbiosciences.com/index.html
Phone: (646) 576-8700
Email: info@intellicellbiosciences.com

Intellicell Biosciences, Inc. SVFC
Regenerative Medicine company using patented technology to manufacuture stromal vascular faction cells containing stem cells for physicians to use under the practice of medicine. Company runs a FDA cGTP cellular lab with SOPs.

Intellicell Biosciences, Inc. SVFC
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Sep 30, 2013 10-Q
CIK 0001125280
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 3841 - Surgical and medical instruments
Incorporated In: NV, USA
Year of Inc. 1999
Employees Not Available
Company Officers/Contacts

Steven Victor CEO, President, Secretary
Company Directors

Steven Victor Chairman
Leonard Mazur
Company Notes

Formerly=Media Exchange Group, Inc. until 7-2011
Formerly=China Wireless Communications, Inc. until 5-2011
Formerly=i-Track, Inc. until 3-03
Service Providers

Auditor/Accountant
Rosen Seymour Shapss Martin & Company LLP
757 Third Ave.
New York, NY, 10017
United States

Legal Counsel
Sichenzia Ross Friedman Ference LLP
61 Broadway
New York, NY, 10006
United States

Investor Relations Firm
Alliance Advisors, LLC
420 Lexington Ave
New York, NY, 10170
United States


Intellicell Biosciences, Inc. SVFC
SVFC Security Details

Share Structure

Market Value1 $3,134,922 a/o Mar 10, 2014
Shares Outstanding 316,658,806 a/o Nov 21, 2013
Float Not Available
Authorized Shares Not Available
Par Value  0.001
Shareholders

Shareholders of Record 137 a/o Apr 23, 2012
Security Notes

Capital Change=shs decreased by 1 for 20 split Pay date=12/02/2002.
Capital Change=shs decreased by 1 for 500 split. Pay date=05/06/2011.
Short Selling Data

Short Interest 9,400 (-99.86%)
Feb 14, 2014
Significant Failures to Deliver  No
Transfer Agent(s)



Intellicell Biosciences, Inc. SVFC Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 535 99 -
Cost of Revenue 466 51 -
Gross Profit 69 48 -
Operating Expenses

Research and Development 260 222 285
Sales, General and Admin. 14,680 17,858 2,026
Non-Recurring Items - - -
Other - - -
Operating Income (14,872) (18,032) (2,310)
Income From Continuing Operations

Add'l Income/Expense Items 10,933 (14,503) (880)
Earnings Before Interest and Tax (3,939) (32,535) (3,190)
Interest Expense 213 304 665
Earnings Before Tax (4,152) (32,839) (3,855)
Income Tax - - -
Minority Interest - - -
Equity Earnings Unconsolidated Subsidiary - - -
Net Income Cont. Operations (4,152) (32,839) (3,855)
Non Recurring Events

Discontinued Operations - - -
Extraordinary Items - - -
Effect of Accounting Changes - - -
Other Items - - -
Net Income (4,152) (32,839) (3,855)
Preferred Stock and Other Adjustments - - -
Net Income Applicable to Common Shareholders (4,152) (32,839) (3,855)

Intellicell Biosciences, Inc. SVFC Recent News

SVFC Intellicell Biosciences, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=SVFC&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/SVFC/quote
Stock Chart http://www.otcmarkets.com/stock/SVFC/chart
Company Info http://www.otcmarkets.com/stock/SVFC/company-info
Recent News http://www.otcmarkets.com/stock/SVFC/news
Financials http://www.otcmarkets.com/stock/SVFC/financials
Filings and Disclosure http://www.otcmarkets.com/stock/SVFC/filings
Short Sales http://www.otcmarkets.com/stock/SVFC/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/SVFC/insider-transactions
Research Reports http://www.otcmarkets.com/stock/SVFC/research
Summary http://finance.yahoo.com/q?s=SVFC
Historical Prices http://finance.yahoo.com/q/hp?s=SVFC+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=SVFC
Basic Chart http://finance.yahoo.com/q/bc?s=SVFC+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=SVFC+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=SVFC+Headlines
Press Releases http://finance.yahoo.com/q/p?s=SVFC+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=SVFC+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=SVFC+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=SVFC+Industry
Major Holders http://finance.yahoo.com/q/mh?s=SVFC+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=SVFC+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=SVFC+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=SVFC
Balance Sheet http://finance.yahoo.com/q/bs?s=SVFC
Cash Flow http://finance.yahoo.com/q/cf?s=SVFC+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/SVFC
Market Watch http://www.marketwatch.com/investing/stock/SVFC
Bloomberg http://www.bloomberg.com/quote/SVFC:US
Morningstar http://quotes.morningstar.com/stock/s?t=SVFC
Bussinessweek http://investing.businessweek.com/research/st...icker=SVFC
Barchart http://www.barchart.com/quotes/stocks/SVFC
OTC Short Report http://otcshortreport.com/index.php?index=SVFC
Investopedia http://www.investopedia.com/markets/stocks/SVFC/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Palisade Bio Launches PALI-2108 Study to Combat Crohn’s Disease

Updated Category News Views 142

Exciting Developments in Crohn’s Disease Treatment Today marks a pivotal point as Palisade Bio, Inc. (NASDAQ: PALI), a dynamic clinical-stage biopharmaceutical firm, undertakes a groundbreaking step in medical research by announcing the commencement of patient dosing in their Phase 1b clinical trial. This study is focused on PALI-2108, a novel therapeutic designed...

Continue Reading
Discover How Your $100 Investment in TD Synnex Has Grown

Updated Category News Views 126

Understanding the Growth of Your Investment in TD Synnex Investing in stocks can often feel like navigating a complex maze, especially when evaluating potential growth over time. One standout in the tech industry is TD Synnex (NASDAQ: SNX), a company that has consistently outperformed benchmark indices. Over the past five years, TD Synnex has achieved an annualized return...

Continue Reading
Castor Maritime Inc. Completes Successful Sale and Leaseback

Updated Category News Views 170

Castor Maritime Inc. Completes Successful Sale and Leaseback Castor Maritime Inc. (NASDAQ: CTRM), a versatile player in the global shipping and energy sector, recently announced an exciting development. The company successfully concluded a significant sale and leaseback transaction for its vessel, the M/V Magic Thunder, an impressive Kamsarmax bulk carrier that was built...

Continue Reading
Yamaha's Partnership with Locally Enhances Dealer Collaboration

Updated Category News Views 153

Yamaha Expands Dealer Network with Innovative Omnichannel Solutions Yamaha, a renowned global leader in musical instruments and audio solutions, has recently announced a strategic partnership with Locally. This collaboration aims to elevate the shopping experience for consumers and to strengthen relationships with local retailers. This initiative is particularly...

Continue Reading
POET Technologies Celebrates AI Award Win at Global Tech Awards

Updated Category News Views 73

POET Technologies' Landmark Achievement in Artificial Intelligence POET Technologies Inc. (TSX Venture: PTK; NASDAQ: POET), known for its groundbreaking work with the POET Optical Interposer™, has recently been honored with the title of "Best in Artificial Intelligence" at the Global Tech Awards 2024. This prestigious recognition was announced following the awards...

Continue Reading